Skip to main content
Equibles

Jonathan Cohen

CEO

20/20 Biolabs, Inc. (AIDX)

Board Member

20/20 Biolabs, Inc. (AIDX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan Cohen

Jonathan Cohen is recorded as CEO and Board Member at 20/20 Biolabs, Inc. (AIDX). The proxy statement of 20/20 Biolabs, Inc. reports total compensation of $325,499 for Jonathan Cohen in fiscal 2025, including a base salary of $250,000. Disclosed compensation is on record for 2 fiscal years. Jonathan Cohen has spoken on 1 investor event across 1 company, most recently for 20/20 Biolabs, Inc. on March 31, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at 20/20 Biolabs, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 20/20 Biolabs, Inc. (AIDX) $250,000 $325,499
2024 20/20 Biolabs, Inc. (AIDX) $250,000 $796,257

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.